abstract |
The present invention relates to novel neuropeptide Y analogs, pharmaceutical compositions comprising the same, pharmaceutical formulations comprising the same and methods of treating diseases or conditions mediated by the binding of neuropeptide Y-receptors. More specifically, the present invention selectively binds to the neuropeptide Y1 receptor subtype compared to the neuropeptide Y2 receptor subtype, having a proline substitution and other substitution (s) at position 34 as defined herein. Novel neuropeptide Y analogs. |